Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
8.00
+0.19 (2.43%)
At close: Feb 20, 2026, 4:00 PM EST
7.99
-0.01 (-0.12%)
After-hours: Feb 20, 2026, 7:53 PM EST
Immix Biopharma Market Cap
Immix Biopharma has a market cap or net worth of $421.56 million as of February 20, 2026. Its market cap has increased by 658.68% in one year.
Market Cap
421.56M
Enterprise Value
406.72M
1-Year Change
658.68%
Ranking
Category
Stock Price
$8.00
Market Cap Chart
Since the IPO on December 16, 2021, Immix Biopharma's market cap has increased from $65.74M to $421.56M, an increase of 541.22%. That is a compound annual growth rate of 55.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 421.56M | 52.96% |
| Dec 31, 2025 | 275.60M | 355.41% |
| Dec 31, 2024 | 60.52M | -55.98% |
| Dec 29, 2023 | 137.48M | 331.07% |
| Dec 30, 2022 | 31.89M | -32.18% |
| Dec 31, 2021 | 47.02M | -28.48% |
| Dec 16, 2021 | 65.74M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lineage Cell Therapeutics | 431.34M |
| REGENXBIO | 425.74M |
| Absci | 418.03M |
| Assembly Biosciences | 410.77M |
| Immutep | 410.75M |
| Entrada Therapeutics | 409.18M |
| Enanta Pharmaceuticals | 406.27M |
| Rocket Pharmaceuticals | 404.75M |